CCNF and pancreatic adenocarcinoma: Here, the analysis of TCGA dataset of 177 pancreatic adenocarcinoma patients showed that mRNA expression levels of CCNF were significantly elevated in 57.63% of PDACs and associated with more advanced and aggressive tumors and poor patient survival.